Dealing with childhood pneumonia in developing countries: How can we make a difference?

Archives of Disease in Childhood

Volumn 92, Issue 4, 2007, Pages 286-288

  Bhutta, Zulfiqar A ^a  

^a AGA KHAN UNIVERSITY   (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; COTRIMOXAZOLE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; PNEUMOCOCCUS VACCINE; PROCAINE PENICILLIN;

ANTIBIOTIC RESISTANCE; BACTERIAL PNEUMONIA; CAUSE OF DEATH; CHILDHOOD DISEASE; CHILDHOOD MORTALITY; DEVELOPING COUNTRY; DIAGNOSTIC TEST; DISEASE SEVERITY; HEALTH CARE POLICY; HUMAN; INFECTION CONTROL; INFLUENZA; MORBIDITY; NEWBORN INFECTION; NEWBORN MORTALITY; PATHOPHYSIOLOGY; PNEUMONIA; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE; SHORT SURVEY; SOCIOECONOMICS; STREPTOCOCCUS INFECTION; TREATMENT DURATION; TREATMENT FAILURE; VACCINATION;

AMOXICILLIN; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; DEVELOPING COUNTRIES; HUMANS; INFANT; PNEUMONIA, BACTERIAL; TREATMENT OUTCOME;

EID: 34047199711     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.2006.111849     Document Type: Short Survey

References (22)

1. Bryce J, Boschi-Pinto C, Shibuya K, WHO Child Health Epidemiology Reference Group, et al. WHO estimates of the causes of death in children. Lancet 2005;365:1147-52.
2. Rudan I, Tomaskovic L, Boschi-Pinto C, WHO Child Health Epidemiology Reference Group, et al. Global estimate of the incidence of clinical pneumonia among children under five years of age. Bull World Health Organ 2004;82:895-903.
3. Wardlaw T, Salama P, Johansson EW, et al. Pneumonia: the leading killer of children. Lancet 2006;368:1048-50.
4. WHO UNICEF. WHO UNICEF joint statement. Management of pneumonia in community settings. 2004. WHO/FCH/CAH/04.06.
5. Hazir H, Qazi SA, Nisar YB, et al. Comparison of standard versus double dose of amoxicillin in the treatment of non-severe pneumonia in children aged 2-5 months: a multi-centre, double blind, randomized controlled trial in Pakistan. Arch Dis Child 2007;92:291-7.
6. Hazir T, Nisar YB, Qazi SA, et al. Chest radiography in children aged 2-59 months diagnosed with non-severe pneumonia as defined by World Health Organization: descriptive multicentre study in Pakistan. BMJ 2006;333:629.
7. Jain A, Kumar P, Awasthi S. High ampicillin resistance in different biotypes and serotypes of Haemophilus influenzae colonizing the nasopharynx of healthy school-going Indian children. J Med Microbiol, 2006;55, (Pt 2): 133-7.
8. Echave P, Bille J, Audet C, et al. Percentage, bacterial etiology and antibiotic susceptibility of acute respiratory infection and pneumonia among children in rural Senegal. J Trop Pediatr 2003;49:28-32.
9. Keeley DJ, Nkrumah FK, Kapuyanyika C. Randomized trial of sulfamethoxazole + trimethoprim versus procaine penicillin for the outpatient treatment of childhood pneumonia in Zimbabwe. Bull World Health Organ 1990;68:185-92.
10. Straus WL, Qazi SA, Kundi Z, et al. Antimicrobial resistance and clinical effectiveness of cotrimoxazole versus amoxycillin for pneumonia among children in Pakistan: randomised controlled trial. Pakistan Co-trimoxazole Study Group. Lancet 1998;352:270-4.
11. Rasmussen ZA, Bari A, Qazi S, et al. COMET (Cotrimoxazole Multicentre Efficacy) Study Group. Randomized controlled trial of standard versus double dose cotrimoxazole for childhood pneumonia in Pakistan. Bull World Health Organ 2005;83:10-19.
12. Catchup Study Group. Clinical efficacy of cotrimoxazole versus amoxicillin twice daily for treatment of pneumonia: a randomised controlled clinical trial in Pakistan. Arch Dis Child 2002;86:113-18.
13. Pakistan Multicentre Amoxycillin Short Course Therapy (MASCOT) pneumonia study group. Clinical efficacy of 3 days versus 5 days oforal amoxicillin for treatment of childhood pneumonia: a multicentre double-blind trial. Lancet 2002;360:835-41.
14. Agarwal G, Awasthi S, Kabra SK, ISCAP Study Group, et al. Three day versus five day treatment with amoxicillin for non-severe pneumonia in young children: a multicentre randomised controlled trial. BMJ 2004;328:791.
15. Bruce N, McCracken J, Albalak R, et al. Impact of improved stoves, house construction and child location on levels of indoor air pollution exposure in young Guatemalan children. J Expo Anal Environ Epidemiol 2004;14(Suppl 1):S26-33.
16. Kirkwood BR, Gove S, Rogers S, et al. Potential interventions for the prevention of childhood pneumonia in developing countries: a systematic review. Bull World Health Organ 1995;73:793-8.
17. Victora CG, Kirkwood BR, Ashworth A, et al. Potential interventions for the prevention of childhood pneumonia in developing countries: improving nutrition. Am J Clin Nutr 1999;70:309-20.
18. Luby SP, Agboatwalla M, Feikin DR, et al. Effect of hand washing on child health: a randomised controlled trial. Lancet 2005;366:225-33.
19. Cowgill KD, Ndiritu M, Nyiro J, et al. Effectiveness of Haemophilus influenzae type b conjugate vaccine introduction into routine childhood immunization in Kenya. JAMA 2006;296:671-8.
20. Adegbola RA, Secka O, Lahai G, et al. Elimination of Haemophilus influenzae type b (Hib) disease from The Gambia after the introduction of routine immunisation with a Hib conjugate vaccine: a prospective study. Lancet 2005;366:144-50.
21. Cutis FT, Zaman SM, Enwere G, Gambian Pneumococcal Vaccine Trial Group, et al. Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial. Lancet 2005;365:1139-46.
22. Klugman KP, Madhi SA, Huebner RE, Vaccine TriaTists Group, et al. A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection. N Engl J Med 2003;349:1341-8.